273 related articles for article (PubMed ID: 30851175)
21. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.
Okamoto M; Miyake T; Kitai K; Furukawa S; Yamamoto S; Senba H; Kanzaki S; Deguchi A; Koizumi M; Ishihara T; Miyaoka H; Yoshida O; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y
PLoS One; 2018; 13(4):e0195147. PubMed ID: 29664906
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
[TBL] [Abstract][Full Text] [Related]
23. Triglyceride-glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Clin Exp Nephrol; 2019 Jul; 23(7):948-955. PubMed ID: 30955189
[TBL] [Abstract][Full Text] [Related]
24. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
25. Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
Jung HS; Chang Y; Kwon MJ; Sung E; Yun KE; Cho YK; Shin H; Ryu S
Am J Gastroenterol; 2019 Mar; 114(3):453-463. PubMed ID: 30353055
[TBL] [Abstract][Full Text] [Related]
26. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
[TBL] [Abstract][Full Text] [Related]
27. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
[TBL] [Abstract][Full Text] [Related]
28. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
29. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
Joo EJ; Chang Y; Yeom JS; Ryu S
Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771
[TBL] [Abstract][Full Text] [Related]
31. The association of sleep duration and sleep quality with non-alcoholic fatty liver disease in a Taiwanese population.
Chou YT; Cheng HJ; Wu JS; Yang YC; Chou CY; Chang CJ; Lu FH
Obes Res Clin Pract; 2018; 12(6):500-505. PubMed ID: 29929928
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.
Du T; Sun X; Yuan G; Zhou X; Lu H; Lin X; Yu X
Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):63-69. PubMed ID: 27956025
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
34. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
Yamada G; Hagiwara Y; Kimura T; Takeuchi Y; Oba K; Masuda K; Matsuyama Y
Am J Gastroenterol; 2021 Apr; 116(4):733-740. PubMed ID: 33982943
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease.
Shen X; Jin C; Wu Y; Zhang Y; Wang X; Huang W; Li J; Wu S; Gao X
J Hum Nutr Diet; 2019 Dec; 32(6):802-809. PubMed ID: 31209928
[TBL] [Abstract][Full Text] [Related]
36. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study.
Wang S; Zhang C; Zhang G; Yuan Z; Liu Y; Ding L; Sun X; Jia H; Xue F
BMJ Open; 2016 Jun; 6(6):e010342. PubMed ID: 27251683
[TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women.
Tokita Y; Maejima Y; Shimomura K; Takenoshita S; Ishiyama N; Akuzawa M; Shimomura Y; Nakajima K
Intern Med; 2017; 56(7):763-771. PubMed ID: 28381741
[TBL] [Abstract][Full Text] [Related]
38. Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
Xu L; Xie J; Chen S; Chen Y; Yang H; Miao M; Zhu Z; Li Y; Yu C; Xu C
Am J Gastroenterol; 2020 Jun; 115(6):876-884. PubMed ID: 32282335
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic Association of Nonalcoholic Fatty Liver Disease and Urinary Calculi: a Population-based Cross-sectional Study in Southern China.
Wei YP; Lin XG; He RQ; Shen J; Sun SL; Chen G; Wang QY; Xu JF; Mo ZN
Iran J Kidney Dis; 2018 Mar; 12(2):112-119. PubMed ID: 29507274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
